AIDx – AI Diagnostics Excellence Cluster
| Reference number | |
| Coordinator | Region Uppsala - Klinisk mikrobiologi och vårdhygien Akademiska sjukhuset |
| Funding from Vinnova | SEK 1 500 000 |
| Project duration | October 2025 - March 2026 |
| Status | Ongoing |
| Venture | Cluster of Excellence for Cutting-Edge Technologies - calls for proposals |
| Call | Visions for world-leading research and innovation in strategic technology areas |
Purpose and goal
AIDx aims to establish an excellence cluster for AI-supported sequencing-based precision diagnostics, developed from healthcare for healthcare in close collaboration with the diagnostic laboratories, Genomic Medicine Sweden, Clinical Genomics, universities, patient organizations, and industry. The cluster will create robust workflows to support diagnosticians and clinicians and improve diagnostics of cancer, rare diseases, and infectious diseases.
Expected effects and result
The pre-project will establish the foundation for an excellence cluster to make AI-driven diagnostics a standard in Swedish healthcare by 2035, focusing on cancer, rare diseases, and infectious diseases. It will define governance, prioritize clinical use cases, and plan shared infrastructure and data management. The outcome is a nationally aligned roadmap enabling more precise and faster diagnostics, personalized care, enhanced efficiency, and reduced costs.
Planned approach and implementation
AIDx builds on the established infrastructure of Genomic Medicine Sweden (GMS) and the SciLifeLab Clinical Genomics platform, linking seven university hospitals and medical faculties. The National Genomics Platform (NGP) serves as a central resource for data storage and AI tools. Academia, healthcare, industry, and patient organizations are engaged through workshops and continuous dialogue. The project is led by experienced experts in clinical genomics and data science within GMS.